A. N. Cheglakov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
A. N. Cheglakov has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- A. M. Belousov
Saint Petersburg State University
3 shared publications - Kirill G. Shostka
Saint Petersburg State University
3 shared publications - N. V. Mankevich
Saint Petersburg State University
3 shared publications
Latest Publications
- 9 September 2025
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 9,p. 69-77
Completion pancreatectomy for postoperative complications after pancreatoduodenectomy
Objective. To analyze the most well-known studies devoted to completion pancreatectomy (CP) for postoperative complications after pancreatoduodenectomy. Material and methods. We analyzed original articles and reviews between 1992 and 2023 (number of patients ≥5 (5—120)). Results. Mean blood loss in CP ranged from 500 to 2180 ml, surgery time — from 144 to 340 min. Along with standard postoperative complications (fluid collection, abscesses, bile leak and bleeding), patients had high risk of venous gastric congestion. The incidence of relaparotomies ranged from 7% to 63% with postoperative mortality up to 64%. Conclusion. A new clinical entity (fulminant necrotizing pancreatitis) as an absolute indication for CP will adjust surgical tactics and contribute to differential analysis of treatment outcomes in this category of patients.
- 9 September 2025
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 9,p. 69-77
Completion pancreatectomy for postoperative complications after pancreatoduodenectomy
Objective. To analyze the most well-known studies devoted to completion pancreatectomy (CP) for postoperative complications after pancreatoduodenectomy. Material and methods. We analyzed original articles and reviews between 1992 and 2023 (number of patients ≥5 (5—120)). Results. Mean blood loss in CP ranged from 500 to 2180 ml, surgery time — from 144 to 340 min. Along with standard postoperative complications (fluid collection, abscesses, bile leak and bleeding), patients had high risk of venous gastric congestion. The incidence of relaparotomies ranged from 7% to 63% with postoperative mortality up to 64%. Conclusion. A new clinical entity (fulminant necrotizing pancreatitis) as an absolute indication for CP will adjust surgical tactics and contribute to differential analysis of treatment outcomes in this category of patients.
- Open Access
- 19 June 2025
- Published by N.N. Blokhin Cancer Fund in Surgery and Oncology
- Vol. 15 (2) , 22-31
Results of treatment of patients with tumor lesions of the lateral pelvic wall. Experience of 10 years
Introduction. Pelvic side wall could be involved by tumor or desmoplastic reaction in patients with gynaecological pelvic malignancies and rectal cancer. Up until recently surgery was considered to have no prospects due to high frequency of palliative procedures and low survival rate.Aim. To conduct a retrospective analysis of short- and long-term results in patients after laterally extended endopelvic resection.Materials and methods. This study included consecutive patients between 2013 and 2023, who undergone laterally extended endopelvic resection at the Leningrad Regional Oncology Center named by L.D. Roman. Principal data were collected and classified. G. Vizzielli and R. Naik classification formed the grounds for surgery type selection. Procedure was considered to be radical with no signs of macro- and microscopic tumor presence in surgical margins.Results. Over the 2013 to 2023 period 54 laterally extended endopelvic resections were performed. Of these, 50 (92.6 %) were woman and 4 (7.4 %) men. An R0 resection was performed in 44 (81 %) of 54 cases, postoperative morbidity was 67 % with 5,6 % mortality, and 5-year overall survival of 23 %. 5-year overall survival was reached only in patients with colorectal cancer (44 %) and uterus tumors (40 %). In case of palliative procedures (R1/R2 resection) overall survival was less than 3 years.Conclusion. Clear resection margin was considered to be the crucial prognostic factor. An improvement of surgical techniques, an exploration of pelvic side wall structures, and sensible patient selection could improve short- and long-term outcomes in this complex group of patients.
- 19 June 2025
- Published by N.N. Blokhin Cancer Fund in Surgery and Oncology
- Vol. 15 (2) , 22-31
Open AccessResults of treatment of patients with tumor lesions of the lateral pelvic wall. Experience of 10 years
Introduction. Pelvic side wall could be involved by tumor or desmoplastic reaction in patients with gynaecological pelvic malignancies and rectal cancer. Up until recently surgery was considered to have no prospects due to high frequency of palliative procedures and low survival rate.Aim. To conduct a retrospective analysis of short- and long-term results in patients after laterally extended endopelvic resection.Materials and methods. This study included consecutive patients between 2013 and 2023, who undergone laterally extended endopelvic resection at the Leningrad Regional Oncology Center named by L.D. Roman. Principal data were collected and classified. G. Vizzielli and R. Naik classification formed the grounds for surgery type selection. Procedure was considered to be radical with no signs of macro- and microscopic tumor presence in surgical margins.Results. Over the 2013 to 2023 period 54 laterally extended endopelvic resections were performed. Of these, 50 (92.6 %) were woman and 4 (7.4 %) men. An R0 resection was performed in 44 (81 %) of 54 cases, postoperative morbidity was 67 % with 5,6 % mortality, and 5-year overall survival of 23 %. 5-year overall survival was reached only in patients with colorectal cancer (44 %) and uterus tumors (40 %). In case of palliative procedures (R1/R2 resection) overall survival was less than 3 years.Conclusion. Clear resection margin was considered to be the crucial prognostic factor. An improvement of surgical techniques, an exploration of pelvic side wall structures, and sensible patient selection could improve short- and long-term outcomes in this complex group of patients.
- Open Access
- 30 November 2024
- Published by N.N. Blokhin Cancer Fund in Surgery and Oncology
- Vol. 14 (4) , 43-54
Extended pelvic evisceration with lateral wall resection in malignant tumors
Patients with tumor involvement of lateral pelvic sidewall represent a peculiar category and were not assessed as the candidates for curative surgery up until recent years. The aim of the current review of literature is to display the working results of the most experienced surgical oncologists in pelvic surgery. We have analyzed issue-related articles, which were published from 1967 till 2023, considering the free margin status as a key prognostic factor. It is elucidated that R0 resection could be achieved in more than a half cases, 5 year overall survival ran up to 50 %, and postoperative mortality was less than 7 %. The majority of authors described high morbidity though (up to 82 %). Exenteration with laterally extended endopelvic resection could improve overall survival rate in patients with locally advanced pelvic malignancies granting sensible patient selection in expert medical care unit.
- 30 November 2024
- Published by N.N. Blokhin Cancer Fund in Surgery and Oncology
- Vol. 14 (4) , 43-54
Open AccessExtended pelvic evisceration with lateral wall resection in malignant tumors
Patients with tumor involvement of lateral pelvic sidewall represent a peculiar category and were not assessed as the candidates for curative surgery up until recent years. The aim of the current review of literature is to display the working results of the most experienced surgical oncologists in pelvic surgery. We have analyzed issue-related articles, which were published from 1967 till 2023, considering the free margin status as a key prognostic factor. It is elucidated that R0 resection could be achieved in more than a half cases, 5 year overall survival ran up to 50 %, and postoperative mortality was less than 7 %. The majority of authors described high morbidity though (up to 82 %). Exenteration with laterally extended endopelvic resection could improve overall survival rate in patients with locally advanced pelvic malignancies granting sensible patient selection in expert medical care unit.